CABP is a transition state analogue of ribulose-1,5-bisphosphate carboxylase/oxygenase (rubisco). References: Donald BJ, Surani S, Deol HS, Mbadugha UJ, Udeani G. Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy. Drug Des Devel Ther. 2017 Dec 13;13559-3566. doi: 10.2147/DDDT.S119545. eCollection 2017. Review. PubMed PMID: 29263651; PubMed Central PMCID: PMC5732564.

纯度：≥98%

CAS：27442-42-8